Skip to main content
Erschienen in: International Journal of Hematology 3/2019

09.12.2018 | Case Report

Complete remission of pure white cell aplasia associated with thymoma after thymectomy and cyclosporine administration

verfasst von: Yuji Kobayashi, Koji Ando, Tomoko Hata, Yoshitaka Imaizumi, Kazuhiro Nagai, Rena Kamijyo, Takeharu Katoh, Jun Taguchi, Hidehiro Itonaga, Shinya Sato, Yasushi Sawayama, Yasushi Miyazaki

Erschienen in: International Journal of Hematology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

We present the case of a 63-year-old male with pure white cell aplasia (PWCA), a rare complication of thymoma, who was successfully treated with cyclosporine A (CyA) and thymectomy. The patient presented with high fever and agranulocytosis. Complete blood count revealed a white blood cell count of 0.9 × 109/L (3% neutrophils), a hemoglobin level of 15.8 g/dL, and a platelet count of 308 × 109/L. Bone marrow (BM) aspiration revealed a hypocellular marrow lacking granulocytes. Computed tomography showed a large anterior mediastinal mass, and the patient was diagnosed with PWCA associated with thymoma. Thirteen days after the initiation of CyA treatment, myeloid cells appeared in the BM, and the neutrophil count in peripheral blood started to increase on day 18. Thymectomy was performed 3 months later. Although CyA treatment was discontinued after thymectomy, complete remission has been maintained for over 4 years. In vitro colony-forming unit granulocyte–macrophage (CFU-GM) assay using the patient’s serum showed severe suppression of CFU-GM colonies in the presence of the patient’s serum, suggesting the presence of CFU-GM inhibitor in the patient’s serum. The efficacy of the immunosuppressive therapy and the CFU-GM assay suggests the potential involvement of an immunological mechanism in patients with thymoma-associated PWCA.
Literatur
1.
Zurück zum Zitat Levitt LJ. Chlorpropamide-induced pure white cell aplasia. Blood. 1987;69:394–400.PubMed Levitt LJ. Chlorpropamide-induced pure white cell aplasia. Blood. 1987;69:394–400.PubMed
2.
Zurück zum Zitat Tamura H, Okamoto M, Yamashita T, Sato C, Watanabe A, Kondo A, et al. Pure white cell aplasia: report of the first case associated with primary biliary cirrhosis. Int J Hematol. 2007;85:97–100.CrossRefPubMed Tamura H, Okamoto M, Yamashita T, Sato C, Watanabe A, Kondo A, et al. Pure white cell aplasia: report of the first case associated with primary biliary cirrhosis. Int J Hematol. 2007;85:97–100.CrossRefPubMed
3.
Zurück zum Zitat Levitt LJ, Ries CA, Greenberg PL. Pure white-cell aplasia. Antibody-mediated autoimmune inhibition of granulopoiesis. N Engl J Med. 1983;308:1141–6.CrossRefPubMed Levitt LJ, Ries CA, Greenberg PL. Pure white-cell aplasia. Antibody-mediated autoimmune inhibition of granulopoiesis. N Engl J Med. 1983;308:1141–6.CrossRefPubMed
4.
Zurück zum Zitat Iida S, Noda T, Banno S, Nitta M, Takada K, Yamamoto M. Pure white cell aplasia (PWCA) with an inhibitor against colony-forming unit of granulocyte-macrophage (CFU-GM). Rinsho Ketsueki. 1990;31:1726–30.PubMed Iida S, Noda T, Banno S, Nitta M, Takada K, Yamamoto M. Pure white cell aplasia (PWCA) with an inhibitor against colony-forming unit of granulocyte-macrophage (CFU-GM). Rinsho Ketsueki. 1990;31:1726–30.PubMed
5.
Zurück zum Zitat Ackland SP, Bur ME, Adler SS, Robertson M, Baron JM. White blood cell aplasia associated with thymoma. Am J Clin Pathol. 1988;89:260–3.CrossRefPubMed Ackland SP, Bur ME, Adler SS, Robertson M, Baron JM. White blood cell aplasia associated with thymoma. Am J Clin Pathol. 1988;89:260–3.CrossRefPubMed
6.
Zurück zum Zitat Mamus SW, Burton JD, Groat JD, Schulte DA, Lobell M, Zanjani ED. Ibuprofen-associated pure white-cell aplasia. N Engl J Med. 1986;314:624–5.CrossRefPubMed Mamus SW, Burton JD, Groat JD, Schulte DA, Lobell M, Zanjani ED. Ibuprofen-associated pure white-cell aplasia. N Engl J Med. 1986;314:624–5.CrossRefPubMed
7.
Zurück zum Zitat Herzog-Tzarfati K, Shiloah E, Koren-Michowitz M, Minha S, Rapoport MJ. Successful treatment of prolonged agranulocytosis caused by acute parvovirus B19 infection with intravenous immunoglobulins. Eur J Intern Med. 2006;17:439–40.CrossRefPubMed Herzog-Tzarfati K, Shiloah E, Koren-Michowitz M, Minha S, Rapoport MJ. Successful treatment of prolonged agranulocytosis caused by acute parvovirus B19 infection with intravenous immunoglobulins. Eur J Intern Med. 2006;17:439–40.CrossRefPubMed
8.
Zurück zum Zitat Yip D, Rasko JE, Lee C, Kronenberg H, O’Neill B. Thymoma and agranulocytosis: two case reports and literature review. Br J Haematol. 1996;95:52–6.CrossRefPubMed Yip D, Rasko JE, Lee C, Kronenberg H, O’Neill B. Thymoma and agranulocytosis: two case reports and literature review. Br J Haematol. 1996;95:52–6.CrossRefPubMed
9.
Zurück zum Zitat Risitano AM, Selleri C, Serio B, Torelli GF, Kulagin A, Maury S, et al. Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA. Br J Haematol. 2010;148:791–6.CrossRefPubMed Risitano AM, Selleri C, Serio B, Torelli GF, Kulagin A, Maury S, et al. Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA. Br J Haematol. 2010;148:791–6.CrossRefPubMed
10.
Zurück zum Zitat Alvares CL, Svasti-Salee D, Rowley M, Gordon-Smith EC, Marsh JCW. Remission induced by Campath-1H for thymoma-associated agranulocytosis. Ann Hematol. 2004;83:398–400.CrossRefPubMed Alvares CL, Svasti-Salee D, Rowley M, Gordon-Smith EC, Marsh JCW. Remission induced by Campath-1H for thymoma-associated agranulocytosis. Ann Hematol. 2004;83:398–400.CrossRefPubMed
11.
Zurück zum Zitat Postiglione K, Ferris R, Jaffe JP, Stroncek D. Immune mediated agranulocytosis and anemia associated with thymoma. Am J Hematol. 1995;49:336–40.CrossRefPubMed Postiglione K, Ferris R, Jaffe JP, Stroncek D. Immune mediated agranulocytosis and anemia associated with thymoma. Am J Hematol. 1995;49:336–40.CrossRefPubMed
12.
Zurück zum Zitat Degos L, Faille A, Housset M, Boumsell L, Rabian C, Parames T. Syndrome of neutrophil agranulocytosis, hypogammaglobulinemia, and thymoma. Blood. 1982;60:968–72.PubMed Degos L, Faille A, Housset M, Boumsell L, Rabian C, Parames T. Syndrome of neutrophil agranulocytosis, hypogammaglobulinemia, and thymoma. Blood. 1982;60:968–72.PubMed
13.
Zurück zum Zitat Kobayashi M, Hasegawa T, Iwabuchi S, Fukushima M, Koie H, Kannari K. The effect of thymectomy on myasthenia gravis, thrombocytopenia, and granulocytopenia associated with thymoma: report of a case. Surg Today. 1995;25:1061–5.CrossRefPubMed Kobayashi M, Hasegawa T, Iwabuchi S, Fukushima M, Koie H, Kannari K. The effect of thymectomy on myasthenia gravis, thrombocytopenia, and granulocytopenia associated with thymoma: report of a case. Surg Today. 1995;25:1061–5.CrossRefPubMed
14.
Zurück zum Zitat Baldwin TA, Hogquist KA, Jameson SC. The fourth way? Harnessing aggressive tendencies in the thymus. J Immunol. 2004;173:6515–20.CrossRefPubMed Baldwin TA, Hogquist KA, Jameson SC. The fourth way? Harnessing aggressive tendencies in the thymus. J Immunol. 2004;173:6515–20.CrossRefPubMed
15.
Zurück zum Zitat Fumeaux Z, Beris P, Borisch B, Sarasin FP, Roosnek E, Dayer J-M, et al. Complete remission of pure white cell aplasia associated with thymoma, autoimmune thyroiditis and type 1 diabetes. Eur J Haematol. 2003;70:186–9.CrossRefPubMed Fumeaux Z, Beris P, Borisch B, Sarasin FP, Roosnek E, Dayer J-M, et al. Complete remission of pure white cell aplasia associated with thymoma, autoimmune thyroiditis and type 1 diabetes. Eur J Haematol. 2003;70:186–9.CrossRefPubMed
16.
Zurück zum Zitat Wu X, Wang S, Lu X, Shen W, Qiao C, Wu Y, et al. Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center. Int J Hematol. 2018;108:123–9.CrossRefPubMed Wu X, Wang S, Lu X, Shen W, Qiao C, Wu Y, et al. Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center. Int J Hematol. 2018;108:123–9.CrossRefPubMed
Metadaten
Titel
Complete remission of pure white cell aplasia associated with thymoma after thymectomy and cyclosporine administration
verfasst von
Yuji Kobayashi
Koji Ando
Tomoko Hata
Yoshitaka Imaizumi
Kazuhiro Nagai
Rena Kamijyo
Takeharu Katoh
Jun Taguchi
Hidehiro Itonaga
Shinya Sato
Yasushi Sawayama
Yasushi Miyazaki
Publikationsdatum
09.12.2018
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 3/2019
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-018-02573-y

Weitere Artikel der Ausgabe 3/2019

International Journal of Hematology 3/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.